Top News

Nov 22, 2016
By Pharmaceutical Technology Editors
Shire plans to establish a 550,000-square-foot campus that will focus on innovation in rare diseases and highly specialized conditions.
Nov 09, 2016
What’s ahead for the healthcare and pharmaceutical industries?
Oct 27, 2016
By Pharmaceutical Technology Editors
Teva and IBM expanded their partnership to focus on drug development and chronic disease management.
Oct 21, 2016
By Pharmaceutical Technology Editors
BASF announced that steamcrackers are slowly being restarted at the company’s plant in Ludwigshafen.
Oct 13, 2016
A UK appeals court ruled against Pfizer, saying generic-drug makers did not infringe on Lyrica’s pain patent.
Oct 07, 2016
Mylan reached a $485-million settlement with the Department of Justice over questions raised about the Medicaid rebate classification of EpiPen.
Sep 26, 2016
By Pharmaceutical Technology Editors
Pfizer announced its decision to remain one company after debating the possibility of splitting Pfizer Innovative Health and Pfizer Essential Health into two, separate publicly traded companies.
Sep 21, 2016
The House Committee on Oversight and Government Reform questioned Heather Bresch during a hearing on the company’s decision to raise the price of EpiPen more than 400%.
Sep 20, 2016
By Pharmaceutical Technology Editors
Walmsley will succeed Andrew Witty as CEO of the British drug maker.
Sep 19, 2016
The agency granted accelerated approval to Sarepta’s controversial DMD treatment, under the condition the company conduct additional studies to demonstrate efficacy.
lorem ipsum